O. Becquart
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
-
- Myasthenia Gravis and Thymoma
- Autoimmune Neurological Disorders and Treatments
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Cutaneous Melanoma Detection and Management 2
- Cancer Diagnosis and Treatment 2
-
- Melanoma and MAPK Pathways 2
- Retinal Development and Disorders 1
- Co-authors
- B. Guillot (9 shared papers)O. Dereure (3 shared papers)C. Lesage (2 shared papers)Laure Cayrefourcq (1 shared paper)Catherine Alix‐Panabières (1 shared paper)Laurent Meunier (1 shared paper)Florence Boissière‐Michot (1 shared paper)Sarah Tick (1 shared paper)
- Journals
- Cancers (2 papers)Melanoma Research (1 paper)Journal of Immunotherapy (1 paper)OncoImmunology (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
O. Becquart
11 papers receiving 99 citations
Peers
Comparison fields: 5 of 38
- Oncology 58
- Neurology 24
- Immunology 25
- Ophthalmology 9
- Cancer Research 13
Countries citing papers authored by O. Becquart
This map shows the geographic impact of O. Becquart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Becquart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Becquart more than expected).
Fields of papers citing papers by O. Becquart
This network shows the impact of papers produced by O. Becquart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Becquart. The network helps show where O. Becquart may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Becquart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 34 | |
| 2 | 2020 | 25 | |
| 3 | 2020 | 13 | |
| 4 | 2017 | 10 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 5 | |
| 7 | 2019 | 2 | |
| 8 | 2020 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2015 | 1 | |
| 11 | 2018 | 1 |
About O. Becquart
O. Becquart is a scholar working on Oncology, Molecular Biology, Neurology, Epidemiology and Dermatology, having authored 11 papers that have together received 99 indexed citations. Recurring topics across this work include Nonmelanoma Skin Cancer Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer Diagnosis and Treatment (2 papers), Cancer and Skin Lesions (2 papers), Neuroblastoma Research and Treatments (2 papers) and Retinal Development and Disorders (1 paper). The work is most often cited by research in Oncology (58 citations), Neurology (24 citations), Immunology (25 citations), Ophthalmology (9 citations) and Cancer Research (13 citations). O. Becquart has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include B. Guillot, O. Dereure, C. Lesage, Laure Cayrefourcq, Catherine Alix‐Panabières, Laurent Meunier, Florence Boissière‐Michot, Sarah Tick, Virginie Lafont and Isabelle Audo. Their work appears in journals such as Cancers, Melanoma Research, Journal of Immunotherapy, OncoImmunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.